Shanti1
Administrator
- Messages
- 3,475
I'm in the same boat. My offenders are EBV and Candida krusei and if I stop the antivirals or antifugals, I get MUCH worse. But it begs the question, why are these pathogens gaining the upper hand when most people who are exposed manage to keep them in check?I'm the same too. The antivirals help but don't eradicate the viruses. If there was an antiviral to eradicate the particular virus troubling us, we still need some way to fix our immune system, eg if it was ebv, we could potentially catch ebv again.
Also, a 'normal' person gets ebv mono, than recovers and their immune system keeps it suppressed. I think fixing the immune system is closer to a real cure than an antiviral that could eradicate a virus, but I'd take either.
For now, I have to stay on antivirals to maintain my level of function as well as a few other things. Just using what's available for now. I think even with a cure, age is going to make it harder to recover???
In his recent thread on his article on the connection between EBV, long-Covid, and ME/CFS, Manuel mentions, "This review suggests that in individuals with certain genetic characteristics - specifically those with "weak" HLA-II haplotypes against EBV - this virus can become more easily established"
The HLA I and HLA II regions of chromosome 16 code for MHC I and II receptors on our cells. These receptors help us to distinguish self from non-self and to recognize intracellular (MHC I/ TH1) and extracellular (MHC II /TH2) pathogens. Allele variants in both HLA I and HLA II are associated with varying autoimmune conditions and pathogen susceptibility. I wouldn't be surprised if part of the answer lies there.